5-Star Friday: Our staff pick some gems of health care storytelling
Cashing in on emotions: How pharma profits from medicalizing the normal spectrum of feelings
Why we should all be wary when PR machines promote phase 2 studies
5-Star Friday: More screening, more vitamins and more advocacy can only be good, right?
Xarelto controversy highlights need for more transparency at NEJM